Cyclomedica Europe

Cyclopharm is a successful radiopharmaceutical company servicing the medical profession through:

• Technegas - a successful innovator, manufacturer and distributor specialising in nuclear medicine lung ventilation imaging.
• Molecular Imaging - a provider of PET (positron emission tomography) sterile, injectable unit doses and equipment.

Technegas

Diagnostic imaging equipment to detect lung disease

Cyclopharm's product Technegas was discovered in 1984. Since that time, more than 1,000 Technegas systems have been installed in hospitals throughout the world and more than 1.7 million Technegas patient studies have been completed.

What is the TechnegasPlus system?
The Techengas system is a device which creates Technegas: an ultrafine dispersion of Tc99m labeled carbon used for nuclear medicine ventilation/ perfusion (V/Q) exams. V/Q imaging is the primary technique used to diagnose pulmonary embolism, a life threatening condition and Technegas has proven to be superior compared to the typical aerosol agents including Xenon-133 gas, Krypton-85 gas and Technetium 99m.

What are the advantages of Technegas?
Technegas offers significant advantages over all other agents because it behaves as a true gas allowing its nano-sized particles to penetrate deep into the alveoli where they remain bound to the lining of the alveoli resulting in a very stable image of the highest quality. Showing a higher sensitivity and specificity result over traditional planar V/Q, Technegas is considered the agent of choice for quality SPECT-VQ.